According to the latest report by IMARC Group, titled “Bronchodilators Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026,” the global bronchodilators market size exhibited moderate growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 5% during 2021-2026.Bronchodilators refer to medications that are utilized in the treatment of patients suffering from long-term conditions of narrow and inflamed airways, including asthma, emphysema, chronic obstructive pulmonary disease (COPD), etc. They aid in relieving associated symptoms by relaxing the muscles around the airways or bronchi, clearing mucus from the lungs, and making breathing easier. Bronchodilators are available in various forms of tablets, liquids, nebulizer solutions, metered-doses, dry powder inhalers, etc. At present times, they are also used to improve the effect of inhaled corticosteroids, which assist in reducing inflammation and prevent flare-ups in asthma.
Request Free Sample Report : https://www.imarcgroup.com/bronchodilators-market/requestsample
Market Trends:
The increasing occurrences of acute respiratory infections due to the coronavirus (COVID-19) outbreak is one of the key factors driving the bronchodilators market across the globe. In addition to this, elevating levels of air pollution, the growing number of smokers, and the rising prevalence of air-borne infectious diseases are also propelling the market growth. Besides this, the escalating geriatric population and a considerable increase in consumer spending capacities are further catalyzing the product demand. Moreover, numerous other factors, including improving healthcare infrastructures with advanced diagnostic modalities and shifting preferences towards non-invasive procedures, are also bolstering the market growth. Additionally, several health agencies across the globe are focusing on extensive R&D activities for introducing innovative product variants, which are further expected to fuel the bronchodilators market over the forecasted period.
Ask Analyst for Instant Discount and Download Full Report with TOC & List of Figure: https://www.imarcgroup.com/bronchodilators-market
Competitive Landscape with Key Player:
Abbott Laboratories, AstraZeneca plc, Boehringer Ingelheim International GmbH, F. Hoffmann-La Roche Ltd, GlaxoSmithKline plc, Novartis AG, Pfizer Inc., Sanofi, Teva Pharmaceutical Industries Ltd. and Vectura Group plc.
Breakup by Indication:
Asthma
Chronic Obstructive Pulmonary Disease (COPD)
Others
Breakup by Drug Type:
Sympathomimetics
Anticholinergics
Phosphodiesterase Inhibitor
Combination Drugs
Breakup by Route of Administration:
Oral
Injection
Inhaler
Breakup by Region:
North America
Europe
Asia Pacific
Latin America
Middle East and Africa
Key Highlights of the Report:
Market Performance (2015-2020)
Market Outlook (2021-2026)
Porter’s Five Forces Analysis
Market Drivers and Success Factors
SWOT Analysis
Value Chain
Comprehensive Mapping of the Competitive Landscape
Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.